Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-04 4:15 pm Purchase | 2026-02-17 | 13G | Immunic, Inc. IMUX | Deep Track Capital, LP | 11,454,000 8.690% | 11,454,000 (New Position) | Filing History |
| 2026-02-24 4:38 pm Purchase | 2026-02-17 | 13G | Immunic, Inc. IMUX | Commodore Capital LP | 13,350,121 9.900% | 13,350,121 (New Position) | Filing History |
| 2026-02-24 4:15 pm Purchase | 2026-02-17 | 13G | Immunic, Inc. IMUX | Trails Edge Capital Partners, LP | 11,454,000 8.700% | 11,454,000 (New Position) | Filing History |
| 2026-02-20 6:59 pm Purchase | 2026-02-12 | 13D | Immunic, Inc. IMUX | BIOTECHNOLOGY VALUE FUND L P | 13,630,601 9.990% | 3,845,423 (+39.30%) | Filing History |
| 2026-02-20 4:43 pm Purchase | 2026-02-17 | 13G | Immunic, Inc. IMUX | Vivo Opportunity Fund Holdings, L.P. | 29,126,906 9.990% | 29,126,906 (New Position) | Filing History |
| 2026-02-19 4:30 pm Purchase | 2026-02-17 | 13G | Immunic, Inc. IMUX | Soleus Capital Master Fund, L.P. | 6,792,000 5.500% | 6,792,000 (New Position) | Filing History |
| 2026-02-17 4:41 pm Sale | 2025-12-31 | 13G | Immunic, Inc. IMUX | Alyeska Investment Group, L.P. | 7,500,000 6.240% | -3,750,000 (-33.33%) | Filing History |
| 2026-02-17 4:18 pm Sale | 2025-12-31 | 13G | Immunic, Inc. IMUX | 683 Capital Management, LLC | 7,500,000 5.900% | -3,134,446 (-29.47%) | Filing History |
| 2026-02-13 5:05 pm Sale | 2025-12-31 | 13G | Immunic, Inc. IMUX | Nantahala Capital Management LLC | 10,378,406 8.220% | -256,159 (-2.41%) | Filing History |
| 2026-02-02 10:31 am Unchanged | 2025-12-31 | 13G | Immunic, Inc. IMUX | Aberdeen Group plc | 8,243,941 6.850% | 0 (Unchanged) | Filing History |
| 2025-12-08 11:45 am Purchase | 2025-11-28 | 13G | Immunic, Inc. IMUX | JANUS HENDERSON GROUP PLC JHG | 12,016,444 9.990% | 9,327,362 (+346.86%) | Filing History |
| 2025-11-14 8:04 pm Purchase | 2025-09-30 | 13G | Immunic, Inc. IMUX | Alyeska Investment Group, L.P. | 11,250,000 9.350% | 1,764,064 (+18.60%) | Filing History |
| 2025-11-14 1:39 pm Sale | 2025-09-30 | 13G | Immunic, Inc. IMUX | Avidity Partners Management LP | 4,699,411 4.800% | -916,400 (-16.32%) | Filing History |
| 2025-11-07 4:00 pm Sale | 2025-09-30 | 13G | Immunic, Inc. IMUX | Soleus Private Equity Fund III, L.P. | 1,580,007 1.600% | -5,713,000 (-78.34%) | Filing History |
| 2025-08-14 5:38 pm Purchase | 2025-06-30 | 13G | Immunic, Inc. IMUX | Alyeska Investment Group, L.P. | 9,485,936 9.900% | 9,485,936 (New Position) | Filing History |
| 2025-08-14 4:44 pm Purchase | 2025-06-30 | 13G | Immunic, Inc. IMUX | Nantahala Capital Management LLC | 10,634,565 9.990% | 10,634,565 (New Position) | Filing History |
| 2025-08-14 4:02 pm Purchase | 2025-06-30 | 13G | Immunic, Inc. IMUX | BIOTECHNOLOGY VALUE FUND L P | 9,785,178 9.990% | 882,206 (+9.91%) | Filing History |
| 2025-08-14 2:37 pm Sale | 2025-06-30 | 13G | Immunic, Inc. IMUX | Avidity Partners Management LP | 5,615,811 5.900% | -425,248 (-7.04%) | Filing History |
| 2025-08-12 09:05 am Purchase | 2025-06-30 | 13G | Immunic, Inc. IMUX | Adage Capital Management, L.P. | 10,479,337 9.990% | 9,080,737 (+649.27%) | Filing History |
| 2025-08-08 4:05 pm Purchase | 2025-08-02 | 13G | Immunic, Inc. IMUX | 683 Capital Management, LLC | 10,634,446 9.900% | 10,634,446 (New Position) | Filing History |